Tilray Brands, Inc.: Form 10-Q for the period ended Feb 28, 2026
Filed with the SEC on Apr 1, 2026 and accepted by EDGAR at Apr 1, 2026, 20:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-02-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-12-01 to 2026-02-28 | $206.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-06-01 to 2026-02-28 | $633.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-12-01 to 2026-02-28 | $151.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2025-06-01 to 2026-02-28 | $463.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-12-01 to 2026-02-28 | $55.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2025-06-01 to 2026-02-28 | $169.9m | us-gaap:GrossProfit |
| Research and development | 3 months2025-12-01 to 2026-02-28 | $62.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-06-01 to 2026-02-28 | $181.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-12-01 to 2026-02-28 | −$26.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-06-01 to 2026-02-28 | −$46.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-12-01 to 2026-02-28 | $2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-06-01 to 2026-02-28 | $3.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-12-01 to 2026-02-28 | −$26.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-06-01 to 2026-02-28 | −$71.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-12-01 to 2026-02-28 | −$0.24 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-06-01 to 2026-02-28 | −$0.65 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-12-01 to 2026-02-28 | −$0.24 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-06-01 to 2026-02-28 | −$0.65 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-12-01 to 2026-02-28 | 112,675,734 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-06-01 to 2026-02-28 | 109,657,744 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-06-01 to 2026-02-28 | −$31.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2026-02-28 | $204.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-02-28 | $718.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-02-28 | $2.07bn | us-gaap:Assets |
| Current liabilities | At period end2026-02-28 | $257.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-02-28 | $549.1m | us-gaap:Liabilities |
| Short-term borrowings | At period end2026-02-28 | $8.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2026-02-28 | $1.56bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-26-010907. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.